Süreyya Savaşan

2.1k total citations
81 papers, 943 citations indexed

About

Süreyya Savaşan is a scholar working on Immunology, Hematology and Oncology. According to data from OpenAlex, Süreyya Savaşan has authored 81 papers receiving a total of 943 indexed citations (citations by other indexed papers that have themselves been cited), including 31 papers in Immunology, 25 papers in Hematology and 16 papers in Oncology. Recurrent topics in Süreyya Savaşan's work include Acute Myeloid Leukemia Research (13 papers), Immune Cell Function and Interaction (13 papers) and Acute Lymphoblastic Leukemia research (12 papers). Süreyya Savaşan is often cited by papers focused on Acute Myeloid Leukemia Research (13 papers), Immune Cell Function and Interaction (13 papers) and Acute Lymphoblastic Leukemia research (12 papers). Süreyya Savaşan collaborates with scholars based in United States, Türkiye and China. Süreyya Savaşan's co-authors include Yaddanapudi Ravindranath, Steven Buck, Öner Özdemır, Indira Warrier, Mustafa Büyükavcı, Mark Stout, Anwar N. Mohamed, Esteban Abella, David Ginsburg and Han‐Mou Tsai and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PEDIATRICS.

In The Last Decade

Süreyya Savaşan

76 papers receiving 917 citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Süreyya Savaşan 286 261 208 146 104 81 943
Maruša Debeljak 108 0.4× 128 0.5× 396 1.9× 173 1.2× 155 1.5× 84 870
Min Kyoung Kim 146 0.5× 163 0.6× 227 1.1× 77 0.5× 96 0.9× 62 932
María Isidoro‐García 87 0.3× 185 0.7× 310 1.5× 87 0.6× 84 0.8× 90 1.1k
Patrizia Accorsi 289 1.0× 172 0.7× 266 1.3× 290 2.0× 280 2.7× 111 1.3k
T Nakazawa 78 0.3× 250 1.0× 194 0.9× 119 0.8× 50 0.5× 41 867
B Nabarra 105 0.4× 387 1.5× 317 1.5× 116 0.8× 58 0.6× 63 1.4k
Jenny Meerding 116 0.4× 611 2.3× 294 1.4× 95 0.7× 37 0.4× 22 1.1k
Lars Ødum 70 0.2× 85 0.3× 273 1.3× 74 0.5× 52 0.5× 58 1.0k
Keisuke Tanaka 37 0.1× 183 0.7× 217 1.0× 74 0.5× 93 0.9× 70 938
Carmen Segundo 81 0.3× 369 1.4× 228 1.1× 92 0.6× 57 0.5× 29 850

Countries citing papers authored by Süreyya Savaşan

Since Specialization
Citations

This map shows the geographic impact of Süreyya Savaşan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Süreyya Savaşan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Süreyya Savaşan more than expected).

Fields of papers citing papers by Süreyya Savaşan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Süreyya Savaşan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Süreyya Savaşan. The network helps show where Süreyya Savaşan may publish in the future.

Co-authorship network of co-authors of Süreyya Savaşan

This figure shows the co-authorship network connecting the top 25 collaborators of Süreyya Savaşan. A scholar is included among the top collaborators of Süreyya Savaşan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Süreyya Savaşan. Süreyya Savaşan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhao, Jianlei, Deying Wang, Holly Edwards, et al.. (2024). Panobinostat sensitizes AraC-resistant AML cells to the combination of azacitidine and venetoclax. Biochemical Pharmacology. 228. 116065–116065. 6 indexed citations
2.
Savaşan, Süreyya, et al.. (2023). Identification of Paroxysmal Nocturnal Hemoglobinuria-Type Bone Marrow Mast Cells. Cureus. 15(9). e44919–e44919. 1 indexed citations
3.
Ravindranath, Yaddanapudi, et al.. (2023). Duffy-Null Phenotype-Associated Neutropenia is the Most Common Etiology for Leukopenia/Neutropenia Referrals to a Tertiary Children's Hospital. The Journal of Pediatrics. 262. 113608–113608. 2 indexed citations
4.
Savaşan, Süreyya, et al.. (2023). Short telomere length in autoimmune neutropenia of childhood: A mere coincidence or an association?. SHILAP Revista de lepidopterología. 4(3). 827–828. 1 indexed citations
5.
Yankelevich, Maxim, et al.. (2020). Patterns and correlates of preserved humoral immunity to vaccines in children following allogeneic hematopoietic stem cell transplantation. Pediatric Transplantation. 25(5). e13936–e13936. 2 indexed citations
6.
Sturm, Amy C., Michael B. Armstrong, Deborah Schiff, et al.. (2012). Hereditary Intrinsic Factor Deficiency in Chaldeans. JIMD Reports. 7. 13–18. 4 indexed citations
7.
Stevens, Joshua B., Batoul Y. Abdallah, Guiming Liu, et al.. (2011). Diverse system stresses: common mechanisms of chromosome fragmentation. Cell Death and Disease. 2(6). e178–e178. 56 indexed citations
8.
Savaşan, Süreyya, Indira Warrier, Steven Buck, Joseph Kaplan, & Yaddanapudi Ravindranath. (2007). Increased lymphocyte Fas expression and high incidence of common variable immunodeficiency disorder in childhood Evans’ syndrome. Clinical Immunology. 125(3). 224–229. 23 indexed citations
9.
Savaşan, Süreyya, et al.. (2006). Possible Role of Natural Immune Response against Altered Fibroblasts in the Development of Post‐Operative Adhesions. American Journal of Reproductive Immunology. 55(6). 420–427. 8 indexed citations
10.
Alcasabas, Patricia, et al.. (2006). Vacuolated neuroblastoma cells mimicking FAB L3 lymphoblasts in bone marrow aspirates. Pediatric Blood & Cancer. 48(2). 227–229. 3 indexed citations
11.
Savaşan, Süreyya, Steven Buck, Susana C. Raimondi, et al.. (2006). CD36 (thrombospondin receptor) expression in childhood acute megakaryoblastic leukemia:In vitrodrug sensitivity and outcome. Leukemia & lymphoma. 47(10). 2076–2083. 11 indexed citations
12.
Özdemir, Özgür & Süreyya Savaşan. (2005). Combinational IL-2/IL-15 induction does not further enhance IL-15-induced lymphokine-activated killer cell cytotoxicity against human leukemia/lymphoma cells. Clinical Immunology. 115(3). 240–249. 20 indexed citations
13.
Savaşan, Süreyya, et al.. (2005). Evaluation of cytotoxicity by flow cytometric drug sensitivity assay in childhood T-cell acute lymphoblastic leukemia. Leukemia & lymphoma. 46(6). 833–841. 11 indexed citations
14.
Savaşan, Süreyya, Mustafa Büyükavcı, Stephen H. Buck, & Yaddanapudi Ravindranath. (2004). Leukaemia/lymphoma cell microparticles in childhood mature B cell neoplasms. Journal of Clinical Pathology. 57(6). 651–653. 14 indexed citations
17.
Özgen, Ünsal, Yusuf Türköz, Mark Stout, et al.. (2003). Degradation of vincristine by myeloperoxidase and hypochlorous acid in children with acute lymphoblastic leukemia. Leukemia Research. 27(12). 1109–1113. 11 indexed citations
18.
Savaşan, Süreyya, Öner Özdemır, Fahri Ovalı, Bülent Zülfikar, & Kerim Bora Yılmaz. (1996). Various associations of human parvovirus B19 infection.. PubMed. 46(10). 235–9. 1 indexed citations
19.
Savaşan, Süreyya, et al.. (1996). Monosomy 7 Myeloproliferative Disease Associated with Neurofibromatosis Type I: a Case Report. Journal of Chemotherapy. 8(3). 243–246. 1 indexed citations
20.
Savaşan, Süreyya, et al.. (1992). Kronik Myeloid Lösemi: Klinik, Hematolojik Bulgular Ve Son Tedavi Yöntemleri. Turkiye Klinikleri Tip Bilimleri Dergisi. 12(1). 60–70.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026